Page last updated: 2024-08-24

fadrozole and Hormone-Dependent Neoplasms

fadrozole has been researched along with Hormone-Dependent Neoplasms in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	7 (63.64)	18.2507
2000's	3 (27.27)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E	1
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP	1
Coombes, RC; Dowsett, M; Moore, J; Powles, TJ; Rubens, R; Smith, IE; Smithers, D; Trunet, PF	1
Abe, O; Ando, J; Enomoto, K; Fujiwara, K; Hayashi, K; Hisamatsu, K; Imoto, S; Nomura, Y; Tashiro, H; Tominaga, T	1
Cooper, J; Henderson, IC; Lipton, A; Miller, AA; Mulagha, MT; Navari, R	1
Buzdar, AU; Hortobagyi, GN; Plourde, PV	1
Norton, A; Smith, IE	1
Dowsett, M	1
Smith, IE	1
Buzdar, AU	1
Miller, WR	1

Reviews

7 review(s) available for fadrozole and Hormone-Dependent Neoplasms

Article	Year
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials. Cancer, 2005, Oct-01, Volume: 104, Issue:7 Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles	2005
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. Journal of the National Cancer Institute, 2006, Sep-20, Volume: 98, Issue:18 Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles	2006
Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects. Breast cancer research and treatment, 1998, Volume: 49 Suppl 1 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Fadrozole; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles	1998
Drug and hormone interactions of aromatase inhibitors. Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles	1999
Aromatase inhibitors: a dose-response effect? Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Aminoglutethimide; Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrogens; Fadrozole; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles	1999
A summary of second-line randomized studies of aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles	2001
Aromatase inhibitors in the treatment of advanced breast cancer. Cancer treatment reviews, 1989, Volume: 16, Issue:2 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Nitriles	1989

Trials

3 trial(s) available for fadrozole and Hormone-Dependent Neoplasms

Article	Year
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogens; Estrone; Fadrozole; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	1994
[Phase I study of CGS16949A--a new aromatase inhibitor. Cooperative Study Group for CGS16949A]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2 Topics: Administration, Oral; Adult; Aged; Androgens; Breast Neoplasms; Drug Administration Schedule; Estrogens; Fadrozole; Female; Humans; Menopause; Middle Aged; Neoplasms, Hormone-Dependent	1994
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma. Cancer, 1996, Aug-15, Volume: 78, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogen Antagonists; Fadrozole; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Prospective Studies	1996

Other Studies

1 other study(ies) available for fadrozole and Hormone-Dependent Neoplasms

Article	Year
Aromatase inhibitors in metastatic breast cancer. Seminars in oncology, 1996, Volume: 23, Issue:4 Suppl 9 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles	1996